MentionFox
Home › Executive changes › Phibro Animal Health Corp
Leadership changes · SEC Form 8-K, Item 5.02

Phibro Animal Health Corp executive changes

Every leadership change Phibro Animal Health Corp reported to the SEC under Item 5.02: who left, who was appointed, to what role and from when, quoted from each filing.

Filings2
Departures named1
Latest filing2026-06-26

Phibro Animal Health Corp filed 2 current reports with the SEC under Item 5.02, which covers directors and officers leaving or being appointed, the latest on 2026-06-26. Between them they name 1 person. Each change below is quoted from the filing and linked to it.

Every change, newest first

Filed 2026-06-26 · 8-K

Reported

Employment Agreement Pursuant to the Employment Agreement, Mr. D. Bendheim will serve as the Chief Executive Officer and President of the Company starting on the Effective Date and ending on the date that such employment is terminated by either party pursuant to the termination provisions set forth in the Employment Agreement (such period, the "Term").
Filed 2026-04-14 · 8-K

Departing: Joyce J. Lee, Director, effective 2026-04-15

(a) On April 13, 2026, Ms. Joyce J. Lee, a member of the Board of the Directors (the "Board") of Phibro Animal Health Corporation (the "Company"), informed the Company that she intends to resign from her position as Director of the Company effective April 15, 2026.
Hiring for a seat like this?

Find people with the same kind of experience as the Director at Phibro Animal Health Corp, with the record behind each one.

Find candidates like Director at Phibro Animal Health Corp
Selling to Phibro Animal Health Corp?

New leaders review vendors and budgets in their first months. Get an alert the next time Phibro Animal Health Corp is in the news or changes leadership.

Get an alert when Phibro Animal Health Corp changes leadership

Tools for this story

Each opens in a new tab, filled in for Phibro Animal Health Corp. With no account yet, you sign up free and land on the result.

Where this comes from

A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.

Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.

Cite this page

Permanent URL: https://mentionfox.com/executive-changes/phibro-animal-health
Last updated 2026-09-27
Primary record: SEC filing 1 · SEC filing 2
Phibro Animal Health Corp (PAHC) executive changes: 2 leadership filings. MentionFox, 2026-09-27. https://mentionfox.com/executive-changes/phibro-animal-health